Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study.
Nikki C C WerkmanGema García-SáezJohannes T H NielenJose Tapia-GalisteoFrancisco J Somolinos-SimónM Elena HernandoJunfeng WangLi JiuWim G GoettschCarla J H van der KallenAnnemarie KosterMiranda T SchramHein de VriesNanne K de VriesSimone J P M EussenAnnemariek H M DriessenCoen D A StehouwerPublished in: Diabetologia (2024)
Disease severity suggested by the clusters of type 2 diabetes is not entirely reflected in quality of life. In particular, the MOD cluster does not appear to be moderate in terms of quality of life. Use of the suggested cluster names in practice should be carefully considered, as the non-neutral nomenclature may affect disease perception in individuals with type 2 diabetes and their healthcare providers.